35 results
DEFA14A
NGM
Ngm Biopharmaceuticals Inc
8 May 20
Additional proxy soliciting materials
4:31pm
FRANCISCO, Calif., May 8, 2020 (GLOBE NEWSWIRE) — NGM Biopharmaceuticals, Inc. (Nasdaq: NGM) today announced that, due to public health and safety concerns
S-1/A
EX-1.1
w7d nkthy5gipju
25 Mar 19
IPO registration (amended)
12:00am
8-K
EX-1.1
r5g45 c8j5
6 Jan 21
Results of Operations and Financial Condition
4:24pm
S-3
EX-1.2
8xwchvh
5 Jun 20
Shelf registration
5:23pm
8-K
EX-99.1
twpvia76st zx
6 Jan 21
Results of Operations and Financial Condition
4:24pm